"10.1371_journal.pone.0049974","plos one","2012-12-03T00:00:00Z","Heather Griffin; Zhonglin Wu; Rebecca Marnane; Vincent Dewar; Anco Molijn; Wim Quint; Christine Van Hoof; Frank Struyf; Brigitte Colau; David Jenkins; John Doorbar","National Institute for Medical Research, London, United Kingdom; GlaxoSmithKline Biologicals, Rixensart, Belgium; XpePharma and Science, Wavre, Belgium; DDL Diagnostic Laboratory, Voorburg, The Netherlands","Conceived and designed the experiments: HG ZW VD AM WQ CVH FS BC DJ JD. Performed the experiments: HG ZW RM VD JD DJ. Analyzed the data: HG ZW RM VD AM WQ CVH FS BC DJ JD. Contributed reagents/materials/analysis tools: HG AM WQ BC DJ JD. Wrote the paper: HG ZW BC DJ JD. Peptide selection for antibody generation: JD.","VD, FS, BC and DJ are or were, at the time of the study, employees of GlaxoSmithKline Biologicals, Rixensart. CVH is an employee of XpePharma and Science, Wavre. AM, WQ and DJ are employees of DDL Diagnostic Laboratory. BC and FS own shares and options to shares in GSK. JD is designated inventor on United Kingdom patent PCT/GB97/03321 (filed in December 1997) and PCT/GB01/01176 (filed in April 2001) owned by MRC. There are no other products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Heather Griffin","HG",11,TRUE,10,6,11,5,TRUE,TRUE,FALSE,0,NA,FALSE
